69 related articles for article (PubMed ID: 9224413)
1. Pravastatin increases survival and inhibits natural killer cell enhancement factor in liver transplanted rats.
Kakkis JL; Ke B; Dawson S; Maggard M; Si M; Kaldas F; Cai W; Shau H; Seu P; Sauri H; Busuttil RW; Imagawa DK
J Surg Res; 1997 May; 69(2):393-8. PubMed ID: 9224413
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA
J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577
[TBL] [Abstract][Full Text] [Related]
3. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
Huang WH; Yan Y; De Boer B; Bishop GA; House AK
Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
[TBL] [Abstract][Full Text] [Related]
4. Prolongation of islet allograft survival in mice by combined treatment with pravastatin and low-dose cyclosporine.
Arita S; Kasraie A; Une S; Ohtsuka S; Smith CV; Mullen Y
Cell Transplant; 2001; 10(7):639-44. PubMed ID: 11714199
[TBL] [Abstract][Full Text] [Related]
5. Pravastatin prolongs graft survival in an allogeneic rat model of orthotopic single lung transplantation.
Li Y; Köster T; Mörike C; v Hörsten S; Martin U; Bader M; Haverich A; Simon AR
Eur J Cardiothorac Surg; 2006 Sep; 30(3):515-24. PubMed ID: 16860567
[TBL] [Abstract][Full Text] [Related]
6. Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up.
Stojanovic I; Vrtovec B; Radovancevic B; Radovancevic R; Yazdanbakhsh AP; Thomas CD; Frazier OH
J Heart Lung Transplant; 2005 Sep; 24(9):1235-8. PubMed ID: 16143239
[TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
8. A rat model of chronic allograft liver rejection.
Gao LH; Zheng SS; Zhu YF; Wan YL; Wei GQ; Qian SK; Jiang WJ
Transplant Proc; 2005 Jun; 37(5):2327-32. PubMed ID: 15964409
[TBL] [Abstract][Full Text] [Related]
9. Presensitization accelerates chronic allograft rejection in a heterotopic rat tracheal allograft model with immunosuppression.
Okumoto T; Yamane M; Sano Y; Aoe M; Date H; Shimizu N
Transpl Immunol; 2007 Jun; 17(4):249-54. PubMed ID: 17493527
[TBL] [Abstract][Full Text] [Related]
10. Pre-transplant blood transfusion and cyclosporin A induce long-term hamster cardiac xenograft survival in immunocompetent rats.
Vriens PW; Stoot JH; van der Steenhoven TJ; Hoyt G; Bouwman E; Robbins RC
Xenotransplantation; 2005 Jan; 12(1):63-71. PubMed ID: 15598275
[TBL] [Abstract][Full Text] [Related]
11. Increased efficacy of CSA following rearterialization in the rat OLTX model.
Freise CE; Liu T; Osorio RW; Ferrell L; Ascher NL; Roberts JP
J Surg Res; 1995 Oct; 59(4):493-6. PubMed ID: 7564323
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
Bourges JL; Lallemand F; Agla E; Besseghir K; Dumont JM; BenEzra D; Gurny R; Behar-Cohen F
Mol Vis; 2006 Dec; 12():1461-6. PubMed ID: 17167400
[TBL] [Abstract][Full Text] [Related]
13. Characterization of antioxidant properties of natural killer-enhancing factor-B and induction of its expression by hydrogen peroxide.
Kim AT; Sarafian TA; Shau H
Toxicol Appl Pharmacol; 1997 Nov; 147(1):135-42. PubMed ID: 9356316
[TBL] [Abstract][Full Text] [Related]
14. Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients.
Kobashigawa JA; Moriguchi JD; Laks H; Wener L; Hage A; Hamilton MA; Cogert G; Marquez A; Vassilakis ME; Patel J; Yeatman L
J Heart Lung Transplant; 2005 Nov; 24(11):1736-40. PubMed ID: 16297773
[TBL] [Abstract][Full Text] [Related]
15. 1 alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts.
Redaelli CA; Wagner M; Tien YH; Mazzucchelli L; Stahel PF; Schilling MK; Dufour JF
Hepatology; 2001 Nov; 34(5):926-34. PubMed ID: 11679963
[TBL] [Abstract][Full Text] [Related]
16. Antibody-mediated response in rat liver chronic rejection.
Wan R; Ying W; Zeng L; Deng X; Chen H; Gao L
Transplant Proc; 2011 Jun; 43(5):1976-9. PubMed ID: 21693310
[TBL] [Abstract][Full Text] [Related]
17. Hyperlipidemia after liver transplantation: natural history and treatment with the hydroxy-methylglutaryl-coenzyme A reductase inhibitor pravastatin.
Imagawa DK; Dawson S; Holt CD; Kirk PS; Kaldas FM; Shackleton CR; Seu P; Rudich SM; Kinkhabwala MM; Martin P; Goldstein LI; Murray NG; Terasaki PI; Busuttil RW
Transplantation; 1996 Oct; 62(7):934-42. PubMed ID: 8878387
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of Oxymetholone (CAS NO. 434-07-1) in F344/N Rats and Toxicology Studies of Oxymetholone in B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Aug; 485():1-233. PubMed ID: 12571678
[TBL] [Abstract][Full Text] [Related]
19. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
Sakagawa T; Kiyochi H; Honda K; Kobayashi N
Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
[TBL] [Abstract][Full Text] [Related]
20. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
